Back to News
Market Impact: 0.35

Jefferies lowers Ormat Technologies stock price target on muted outlook

ORASMCIAPP
Analyst InsightsAnalyst EstimatesCorporate EarningsCorporate Guidance & OutlookRenewable Energy TransitionEnergy Markets & PricesCredit & Bond MarketsCompany Fundamentals
Jefferies lowers Ormat Technologies stock price target on muted outlook

Jefferies cut its Ormat (ORA) price target to $122 from $130 and kept a Hold, citing in-line Q4 2025 results and modest 2026 guidance with no near-term catalysts; the stock trades at $109.44 (up ~55% Y/Y) and sits on a P/E of 54.47. Ormat completed a $1.0B convertible senior note offering ( $825M 1.50% Series A and $175M 0.00% Series B, both due 2031) after increasing the planned deal from $750M → $875M → $1B. The company also amended PPAs covering 15MW from Casa Diablo‑IV, extending contracts by five years to 2037 with a 27% price increase, while management reiterated enhanced geothermal targets for 2029/2030 and Jefferies says September Analyst Day will be important for 2030 targets (implying >10% EBITDA CAGR).

Analysis

Market pricing is effectively a call option on a long-dated technology outcome while the underlying operating business generates incremental, contract-backed cash flow. That skew creates a classic “growth but no near-term catalysts” setup: investors will pay a premium for multi‑year upside but are reluctant to fund multiple expansion absent demonstrable technology derisking, so equity performance is likely to track binary newsflow rather than steady fundamentals. Recent financing and contract actions materially change the company’s risk profile: they lengthen runway and lock in higher realized prices on specific assets, which reduces short-term cash risk but introduces a conversion/cap structure that can cap equity upside until the market digests dilution dynamics. Meanwhile the engineering and permitting chain for deep geothermal remains a multi-year, capex‑intensive bottleneck — any acceleration in build activity will likely push equipment/contractor lead times and costs higher, compressing project IRRs versus vendor or model assumptions. Key catalysts are discrete and spaced out: an investor day or published multi‑year targets could reprice optionality if they show credible pathway metrics (drill success rates, step‑change cost curves, demonstrable commercial EGS projects). The primary tail risks are technological underperformance, multi‑year permitting and capex creep, and a market re‑rating triggered by conversion overhang realization — each can unwind the premium over quarters to years depending on news cadence.